Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inflammatory Bowel Disease and Atherosclerosis Development

NCT05781737 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.

NCT NCT05781737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05781737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inflammatory Bowel Disease and Atherosclerosis Development
Lead sponsor
I.M. Sechenov First Moscow State Medical University
Phase
Observational
Overall status
Completed
Start date
November 1, 2022
Completion date
January 30, 2025
Enrollment
115 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial stiffness, cardiovascular diseases, inflammation, inflammatory bowel diseases